Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $799M (100.0% shares, 0.0% debt)

Holdings (23)

NAMS NEWAMSTERDAM PHARMA COMPANY 24.3%
Value $194M Shares 10,719,110 Est. Cost $10.88 Unrealized +67.6%
CIDARA THERAPEUTICS INC 15.2%
Value $122M Shares 2,500,680 Est. Cost $38.04 Unrealized
NUVL NUVALENT INC 13.8%
Value $110M Shares 1,447,267 Est. Cost $28.96 Unrealized +152.6%
PHVS PHARVARIS N V 7.3%
Value $58.14M Shares 3,303,381 Est. Cost $23.89 Unrealized -32.6%
DNTH DIANTHUS THERAPEUTICS INC 5.8%
Value $46.24M Shares 2,482,250 Est. Cost $21.73 Unrealized -13.7%
SVRA SAVARA INC 5.0%
Value $40.13M Shares 17,600,621 Est. Cost $2.08 Unrealized +30.9%
SLDB SOLID BIOSCIENCES INC 4.8%
Value $38.53M Shares 7,911,669 Est. Cost $5.76 Unrealized -38.6%
IRON DISC MEDICINE INC 3.9%
Value $30.9M Shares 583,500 Est. Cost $25.40 Unrealized +85.0%
OLMA OLEMA PHARMACEUTICALS INC 3.6%
Value $29.16M Shares 6,843,954 Est. Cost $9.99 Unrealized -55.4%
RPID RAPID MICRO BIOSYSTEMS INC 3.6%
Value $29.1M Shares 8,434,560 Est. Cost $20.66 Unrealized -85.9%
UPB UPSTREAM BIO INC 3.4%
Value $26.79M Shares 2,439,538 Est. Cost $21.55 Unrealized -57.2%
CABA CABALETTA BIO INC 1.8%
Value $14.71M Shares 9,677,125 Est. Cost $3.63 Unrealized -57.1%
TNGX TANGO THERAPEUTICS INC 1.7%
Value $13.89M Shares 2,712,008 Est. Cost $10.01 Unrealized -75.3%
ANNX ANNEXON INC 1.6%
Value $12.6M Shares 5,249,069 Est. Cost $11.24 Unrealized -82.2%
KYTX KYVERNA THERAPEUTICS INC 1.3%
Value $10.34M Shares 3,368,370 Est. Cost $27.08 Unrealized -90.9%
AVIR ATEA PHARMACEUTICALS INC 1.1%
Value $8.948M Shares 2,485,638 Est. Cost $32.23 Unrealized -90.7%
XLO XILIO THERAPEUTICS INC 0.4%
Value $3.105M Shares 4,566,817 Est. Cost $10.85 Unrealized -93.0%
IPSC CENTURY THERAPEUTICS INC 0.4%
Value $3.023M Shares 5,410,361 Est. Cost $3.16 Unrealized -83.0%
MERSANA THERAPEUTICS INC 0.3%
Value $2.564M Shares 8,663,673 Est. Cost $12.65 Unrealized
CCCC C4 THERAPEUTICS INC 0.2%
Value $1.59M Shares 1,111,910 Est. Cost $29.00 Unrealized -95.0%
IVVD INVIVYD INC 0.2%
Value $1.287M Shares 1,799,595 Est. Cost $37.11 Unrealized -98.1%
XFOR X4 PHARMACEUTICALS INC 0.1%
Value $1.071M Shares 563,859 Est. Cost $4.09 Unrealized 0.0%
NAMSW NEWAMSTERDAM PHARMA COMPANY 0.1%
Value $800K Shares 100,000 Est. Cost $0.86 Unrealized